Quintin J. Lai - Sep 10, 2021 Form 4 Insider Report for WEST PHARMACEUTICAL SERVICES INC (WST)

Role
VP Corp Development & Strategy
Signature
Ryan Metz as Agent for Quintin J. Lai
Stock symbol
WST
Transactions as of
Sep 10, 2021
Transactions value $
-$3,866,283
Form type
4
Date filed
9/14/2021, 10:45 AM
Next filing
Feb 24, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WST Common Stock Options Exercise $517K +8.67K +388.21% $59.64* 10.9K Sep 10, 2021 Direct
transaction WST Common Stock Options Exercise $73K +1K +9.17% $72.97* 11.9K Sep 10, 2021 Direct
transaction WST Common Stock Sale -$2.33M -5.07K -42.6% $460.18 6.83K Sep 10, 2021 Direct F1
transaction WST Common Stock Sale -$1.43M -3.1K -45.36% $460.80 3.73K Sep 10, 2021 Direct F2
transaction WST Common Stock Sale -$694K -1.5K -40.17% $462.63 2.23K Sep 10, 2021 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WST Stock Option (Right to Buy) Options Exercise $0 -8.67K -100% $0.00* 0 Sep 10, 2021 Common Stock 8.67K $59.64 Direct
transaction WST Stock Option (Right to Buy) Options Exercise $0 -1K -100% $0.00* 0 Sep 10, 2021 Common Stock 1K $72.97 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $459.50 to $460.44, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
F2 The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $460.50 to $461.44, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
F3 The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $462.48 to $462.805, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.